Switching Between Second-Generation AntipsychoticsWhy and How?

被引:0
|
作者
Monika Edlinger
Susanne Baumgartner
Nadja Eltanaihi-Furtmüller
Martina Hummer
W. Wolfgang Fleischhacker
机构
[1] Innsbruck Medical University,Department of Biological Psychiatry
来源
CNS Drugs | 2005年 / 19卷
关键词
Clozapine; Risperidone; Olanzapine; Quetiapine; Negative Symptom;
D O I
暂无
中图分类号
学科分类号
摘要
The introduction of second-generation antipsychotics represents an important advance in the treatment of schizophrenia. Although these drugs are generally very effective, not all patients respond in the same way. Partial response with persistent positive and negative symptoms and residual symptoms may force physicians to change antipsychotic medication. As more and more second-generation antipsychotics are introduced, the need for practical guidelines on switching these medications becomes increasingly important.
引用
收藏
页码:27 / 42
页数:15
相关论文
共 50 条
  • [1] Interactions between antiepileptics and second-generation antipsychotics
    de Leon, Jose
    Santoro, Vincenza
    D'Arrigo, Concetta
    Spina, Edoardo
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 311 - 334
  • [2] Second-generation antipsychotics and the metabolic syndrome
    Prakash S. Masand
    Rajnish Mago
    Current Psychiatry Reports, 2005, 7 (3) : 153 - 154
  • [3] Second-generation antipsychotics and constipation: A review of the literature
    De Hert, M.
    Hudyana, H.
    Dockx, L.
    Bernagie, C.
    Sweers, K.
    Tack, J.
    Leucht, S.
    Peuskens, J.
    EUROPEAN PSYCHIATRY, 2011, 26 (01) : 34 - 44
  • [5] Cognitive Effects of Second-Generation AntipsychoticsCurrent Insights into Neurochemical Mechanisms
    Fabio Fumagalli
    Angelisa Frasca
    Giorgio Racagni
    Marco Andrea Riva
    CNS Drugs, 2009, 23 : 603 - 614
  • [6] Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
    Marianne Ulcickas Yood
    Gerald N DeLorenze
    Charles P Quesenberry
    Susan A Oliveria
    Ai-Lin Tsai
    Edward Kim
    Mark J Cziraky
    Robert D McQuade
    John W Newcomer
    Gilbert J L'Italien
    BMC Psychiatry, 11
  • [8] Second-Generation (Atypical) Antipsychotics and Metabolic EffectsA Comprehensive Literature Review
    John W. Newcomer
    CNS Drugs, 2005, 19 (Suppl 1) : 1 - 93
  • [9] Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
    Leucht, Stefan
    Corves, Caroline
    Arbter, Dieter
    Engel, Rolf R.
    Li, Chunbo
    Davis, John M.
    LANCET, 2009, 373 (9657) : 31 - 41
  • [10] Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use
    Fleischhacker, WW
    PSYCHOPHARMACOLOGY, 2003, 169 (02) : 207 - 210